This webinar, the ninth and final session of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind natural killer cell engagers. Basic, clinical and translational researchers in academia and industry and members of the investment community are...
01-11-2023 | 10:00 - 12:00 CT
This webinar, the eighth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind therapies involving T cell receptors. Basic, clinical and translational researchers in academia and industry and members of the investment community are the...
12-07-2022 | 14:00 - 16:00 CT
This webinar, the seventh of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind the enhanced blockade of cytotoxic T lymphocyte antigen-4 . Basic, clinical and translational researchers in academia and industry and members of the...
10-05-2022 | 13:00 - 15:00 CT
This webinar, the sixth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind induced pluripotent stem cell-derived cell therapies. Basic, clinical and translational researchers in academia and industry and members of the investment...
09-26-2022 | 10:00 - 12:00 CT
This webinar, the fourth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind the targeted systemic delivery of innate immune activators. Basic, clinical and translational researchers in academia and industry and members of the investment...
08-26-2022 | 10:00 - 12:00 CT
This webinar, the third of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind tumor-infiltrating lymphocyte therapies. Basic, clinical and translational researchers in academia and industry and members of the investment community are the...
07-28-2022 | 12:00 - 14:00 CT
This is the library for the enduring materials from the Targets in Cancer IO: A Deep Dive, LAG 3 biology and Clinical Results webinar that took place on June 13, 2022. Moderators : Drew M. Pardoll, MD, PhD – Johns Hopkins University Dario A.A. Vignali, PhD – University of...
9 attachments
This webinar, the second of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind recombinant IL-18 immunotherapy. Basic, clinical and translational researchers in academia and industry and members of the investment community are the target...
07-18-2022 | 12:00 - 14:00 CT
On Wednesday, January 26, 2022 from 2 – 3 p.m. ET, join leading experts from the SITC Head and Neck Squamous Cell Carcinoma (HNSCC) Immunotherapy Guideline Expert Panel for "Case Studies in Immunotherapy for the Treatment of HNSCC - SITC CPG Webinar." This high-level webinar will include case...
01-26-2022 | 14:00 - 15:00 ET
On Thursday, January 13, 2022, 12:30-1:30 p.m. EST , join leading experts from the SITC Head and Neck Squamous Cell Carcinoma (HNSCC) Immunotherapy Guideline Expert Panel for "Practical Management Pearls for Immunotherapy for the Treatment of HNSCC – SITC CPG Webinar." This high-level webinar is...
01-13-2022 | 12:30 - 13:30 ET
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us